The short answer
Do not add kava to clozapine without discussing it with the prescribing team. Kava guidance advises against use with sedating substances, and clozapine can cause sedation. Kava also has a separate rare liver-injury risk, but increased liver injury from this exact combination has not been established.
What this answer covers
Piper methysticum oral extracts and beverages; preparation, plant material and co-exposures vary.
- Supplement or preparation
- Piper methysticum
- Medication ingredient
- clozapine
Why sedation is the practical concern
Clozapine can impair alertness and coordination. Federal kava guidance advises against combining kava with substances that have sedative effects. This supports checking with the clozapine prescriber before use, while leaving the frequency and severity of this exact interaction uncertain.
Keep the liver claim separate
Rare serious liver injuries have been linked to several kinds of kava product. Clozapine also has a liver-injury warning. Two separate warnings do not prove the combination increases liver injury beyond either exposure alone. The concern should not be presented as a demonstrated clozapine-kava toxicity syndrome.
Benefit is not assured
In a four-week trial with kava, valerian and placebo groups, kava did not improve anxiety more than placebo. That trial did not examine clozapine co-use. Traditional use or a calming product description does not establish a benefit that offsets the uncertainties of adding kava during clozapine treatment.
Discuss the product before use
Bring the product name, amount and ingredient list to the prescribing team. Kava beverages and extracts are not interchangeable, and alcohol or other sedating medicines can complicate the assessment. No evidence here establishes a safe dose gap or a clozapine dose reduction that makes kava safe to add.
Evidence and practical considerations
Side effects & toxicity
Kava guidance against combining sedating substances supports a precaution with sedating clozapine treatment.
- Exact scope
- Piper methysticum oral extracts and beverages; preparation, plant material and co-exposures vary. with Oral clozapine, RxNorm 2626 IN.
- Medication form and route
- oral clozapine; oral botanical preparation
What remains uncertain
- Indirect official guidance; no pair-specific event rate or severity established.
Factors that may matter: exact botanical preparation; other medicines; baseline drowsiness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed clozapine.
Clozapine can cause sedation and impaired cognitive or motor performance; somnolence and instability can contribute to falls. Severe hepatotoxicity has been reported.
How this applies: Medication-specific safety context only; no direct botanical interaction or automatic dose change is established.
Does not name any of the six botanical counterparties or quantify their combined risks.
Source 2: federal botanical safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of kava drinks and extracts.
Advises against combining kava with sedating substances. Various products have been linked to rare liver injury, sometimes serious or fatal.
How this applies: Botanical-only evidence; relevance to clozapine requires separate interpretation.
Intrinsic liver injury does not prove additive hepatotoxicity with clozapine; preparation and co-exposures are heterogeneous.
Research assessment: · Open full citations ↗
Side effects & toxicity
Both kava products and clozapine have separate liver-injury warnings, but those warnings do not demonstrate additive liver injury from their combination.
- Exact scope
- Piper methysticum oral extracts and beverages; preparation, plant material and co-exposures vary. with Oral clozapine, RxNorm 2626 IN.
- Medication form and route
- oral clozapine; oral botanical preparation
What remains uncertain
- No direct comparative or causal clozapine-kava liver evidence identified.
Factors that may matter: exact botanical preparation; other medicines; baseline drowsiness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed clozapine.
Clozapine can cause sedation and impaired cognitive or motor performance; somnolence and instability can contribute to falls. Severe hepatotoxicity has been reported.
How this applies: Medication-specific safety context only; no direct botanical interaction or automatic dose change is established.
Does not name any of the six botanical counterparties or quantify their combined risks.
Source 2: federal botanical safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of kava drinks and extracts.
Advises against combining kava with sedating substances. Various products have been linked to rare liver injury, sometimes serious or fatal.
How this applies: Botanical-only evidence; relevance to clozapine requires separate interpretation.
Intrinsic liver injury does not prove additive hepatotoxicity with clozapine; preparation and co-exposures are heterogeneous.
Research assessment: · Open full citations ↗
Side effects & toxicity
An anxiety trial did not find kava superior to placebo and cannot establish that adding it to clozapine provides benefit.
- Exact scope
- Piper methysticum oral extracts and beverages; preparation, plant material and co-exposures vary. with Oral clozapine, RxNorm 2626 IN.
- Medication form and route
- oral clozapine; oral botanical preparation
What remains uncertain
- Different population and symptom endpoint; not an interaction trial.
Factors that may matter: exact botanical preparation; other medicines; baseline drowsiness.
Read the supporting source summaries
Source 1: randomized human trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 391 people with anxiety and insomnia.
Neither kava nor valerian improved its primary symptom outcome more than placebo.
How this applies: Botanical-only evidence; relevance to clozapine requires separate interpretation.
No clozapine exposure comparison; efficacy null is not evidence that sedation or interactions cannot occur.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Preparation-specific evidence and uncertainty assessed. | |
| Research summary published |
Article revision: 4bd3fcbc75b8c8ef
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.